Interinstitutional variability in DNA flow cytometric analysis of tumors: The national Cancer Institute's Flow Cytometry Network experience

J. S. Coon, A. D. Deitch, R. W. De Vere White, L. G. Koss, M. R. Melamed, J. E. Reeder, Ronald S Weinstein, R. P. Wersto, L. L. Wheeless

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Flow cytometric DNA analysis of human urinary bladder specimens may be clinically useful for prognosis in transitional cell (urothelial) carcinoma and for detecting recurrence after treatment. However, many important methodological differences exist among institutions which have described this technique, and it has not previously been shown that data from different institutions are comparable. The National Cancer Institute has created a Flow Cytometry Network to address the need for technology assessment of flow cytometry. This report describes the independent flow cytometric analysis and interpretation of 'unknown' paraffin-embedded bladder tumor specimens by the five Network institutions. Although important differences in method existed among the institutions, substantial agreement was achieved in actual data generated and their interpretation. This suggests that a consensus regarding acceptable laboratory performance of this technique could be reached, which should facilitate its more widespread clinical implementation.

Original languageEnglish (US)
Pages (from-to)126-130
Number of pages5
JournalCancer
Volume61
Issue number1
StatePublished - 1988
Externally publishedYes

Fingerprint

National Cancer Institute (U.S.)
Flow Cytometry
Biomedical Technology Assessment
Needs Assessment
Transitional Cell Carcinoma
DNA
Urinary Bladder Neoplasms
Paraffin
Neoplasms
Urinary Bladder
Recurrence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Coon, J. S., Deitch, A. D., De Vere White, R. W., Koss, L. G., Melamed, M. R., Reeder, J. E., ... Wheeless, L. L. (1988). Interinstitutional variability in DNA flow cytometric analysis of tumors: The national Cancer Institute's Flow Cytometry Network experience. Cancer, 61(1), 126-130.

Interinstitutional variability in DNA flow cytometric analysis of tumors : The national Cancer Institute's Flow Cytometry Network experience. / Coon, J. S.; Deitch, A. D.; De Vere White, R. W.; Koss, L. G.; Melamed, M. R.; Reeder, J. E.; Weinstein, Ronald S; Wersto, R. P.; Wheeless, L. L.

In: Cancer, Vol. 61, No. 1, 1988, p. 126-130.

Research output: Contribution to journalArticle

Coon, JS, Deitch, AD, De Vere White, RW, Koss, LG, Melamed, MR, Reeder, JE, Weinstein, RS, Wersto, RP & Wheeless, LL 1988, 'Interinstitutional variability in DNA flow cytometric analysis of tumors: The national Cancer Institute's Flow Cytometry Network experience', Cancer, vol. 61, no. 1, pp. 126-130.
Coon JS, Deitch AD, De Vere White RW, Koss LG, Melamed MR, Reeder JE et al. Interinstitutional variability in DNA flow cytometric analysis of tumors: The national Cancer Institute's Flow Cytometry Network experience. Cancer. 1988;61(1):126-130.
Coon, J. S. ; Deitch, A. D. ; De Vere White, R. W. ; Koss, L. G. ; Melamed, M. R. ; Reeder, J. E. ; Weinstein, Ronald S ; Wersto, R. P. ; Wheeless, L. L. / Interinstitutional variability in DNA flow cytometric analysis of tumors : The national Cancer Institute's Flow Cytometry Network experience. In: Cancer. 1988 ; Vol. 61, No. 1. pp. 126-130.
@article{c258722f546e4470be798db77b3277d2,
title = "Interinstitutional variability in DNA flow cytometric analysis of tumors: The national Cancer Institute's Flow Cytometry Network experience",
abstract = "Flow cytometric DNA analysis of human urinary bladder specimens may be clinically useful for prognosis in transitional cell (urothelial) carcinoma and for detecting recurrence after treatment. However, many important methodological differences exist among institutions which have described this technique, and it has not previously been shown that data from different institutions are comparable. The National Cancer Institute has created a Flow Cytometry Network to address the need for technology assessment of flow cytometry. This report describes the independent flow cytometric analysis and interpretation of 'unknown' paraffin-embedded bladder tumor specimens by the five Network institutions. Although important differences in method existed among the institutions, substantial agreement was achieved in actual data generated and their interpretation. This suggests that a consensus regarding acceptable laboratory performance of this technique could be reached, which should facilitate its more widespread clinical implementation.",
author = "Coon, {J. S.} and Deitch, {A. D.} and {De Vere White}, {R. W.} and Koss, {L. G.} and Melamed, {M. R.} and Reeder, {J. E.} and Weinstein, {Ronald S} and Wersto, {R. P.} and Wheeless, {L. L.}",
year = "1988",
language = "English (US)",
volume = "61",
pages = "126--130",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Interinstitutional variability in DNA flow cytometric analysis of tumors

T2 - The national Cancer Institute's Flow Cytometry Network experience

AU - Coon, J. S.

AU - Deitch, A. D.

AU - De Vere White, R. W.

AU - Koss, L. G.

AU - Melamed, M. R.

AU - Reeder, J. E.

AU - Weinstein, Ronald S

AU - Wersto, R. P.

AU - Wheeless, L. L.

PY - 1988

Y1 - 1988

N2 - Flow cytometric DNA analysis of human urinary bladder specimens may be clinically useful for prognosis in transitional cell (urothelial) carcinoma and for detecting recurrence after treatment. However, many important methodological differences exist among institutions which have described this technique, and it has not previously been shown that data from different institutions are comparable. The National Cancer Institute has created a Flow Cytometry Network to address the need for technology assessment of flow cytometry. This report describes the independent flow cytometric analysis and interpretation of 'unknown' paraffin-embedded bladder tumor specimens by the five Network institutions. Although important differences in method existed among the institutions, substantial agreement was achieved in actual data generated and their interpretation. This suggests that a consensus regarding acceptable laboratory performance of this technique could be reached, which should facilitate its more widespread clinical implementation.

AB - Flow cytometric DNA analysis of human urinary bladder specimens may be clinically useful for prognosis in transitional cell (urothelial) carcinoma and for detecting recurrence after treatment. However, many important methodological differences exist among institutions which have described this technique, and it has not previously been shown that data from different institutions are comparable. The National Cancer Institute has created a Flow Cytometry Network to address the need for technology assessment of flow cytometry. This report describes the independent flow cytometric analysis and interpretation of 'unknown' paraffin-embedded bladder tumor specimens by the five Network institutions. Although important differences in method existed among the institutions, substantial agreement was achieved in actual data generated and their interpretation. This suggests that a consensus regarding acceptable laboratory performance of this technique could be reached, which should facilitate its more widespread clinical implementation.

UR - http://www.scopus.com/inward/record.url?scp=0023838840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023838840&partnerID=8YFLogxK

M3 - Article

C2 - 3334939

AN - SCOPUS:0023838840

VL - 61

SP - 126

EP - 130

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -